(NMR) Nomura Holdings - Ratings and Ratios
Exchange: NYSE • Country: Japan • Currency: USD • Type: Common Stock • ISIN: US65535H2085
NMR: Financial Products, Investment Services, Trading, Underwriting, Advisory
Nomura Holdings Inc ADR (NYSE:NMR) operates as a global financial services provider, offering a comprehensive suite of financial solutions to individuals, corporations, financial institutions, governments, and governmental agencies. The company is organized into three primary business segments: Wealth Management, Investment Management, and Wholesale.
The Wealth Management segment delivers personalized financial products and investment consulting services, catering to high-net-worth individuals and retail clients. This includes retirement planning, estate services, and tailored investment strategies. The Investment Management segment focuses on institutional and retail clients, providing expertise in investment trust management, discretionary investment services, and mutual funds. The Wholesale segment engages in fixed income and equity trading, agency execution, and market-making, along with structured financing and solutions. It also underwrites various securities, including shares, convertible securities, investment-grade and high-yield debts, and emerging market debts. Additionally, the segment provides advisory services for mergers and acquisitions, capital structuring, and risk management solutions.
Nomura Holdings Inc ADR was established in 1925 and is headquartered in Tokyo, Japan. The company was previously known as The Nomura Securities Co., Ltd. and rebranded as Nomura Holdings, Inc. in 2001. With a market capitalization of $16,470.52 million USD, the company is classified under the Investment Banking & Brokerage sub-industry. Its common stock is listed on the NYSE under the ticker symbol NMR.
Based on the provided technical and fundamental data, the 3-month forecast for Nomura Holdings Inc ADR (NYSE:NMR) suggests the following trends:
Technical Data: The stock is currently trading at $5.60, below its 20-day SMA of $5.70 and 50-day SMA of $6.20, indicating potential short-term weakness. The 200-day SMA of $5.86 suggests a neutral long-term trend. ATR of 0.22 indicates low volatility.
Fundamental Data: The P/E ratio of 7.43 and forward P/E of 16.08 suggest undervaluation relative to future earnings expectations. The P/B ratio of 0.65 indicates that the stock is trading below its book value, signaling potential undervaluation. The RoE of 9.46% reflects moderate profitability. Given these factors, the stock may appeal to value investors seeking exposure to the financial sector.
Additional Sources for NMR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NMR Stock Overview
Market Cap in USD | 17,087m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 1961-10-01 |
NMR Stock Ratings
Growth Rating | 29.3 |
Fundamental | 62.1 |
Dividend Rating | 1.0 |
Rel. Strength | -21.5 |
Analysts | 3/5 |
Fair Price Momentum | 4.86 USD |
Fair Price DCF | 15754.55 USD |
NMR Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 71.9% |
NMR Growth Ratios
Growth Correlation 3m | -72.8% |
Growth Correlation 12m | 21.9% |
Growth Correlation 5y | 33.7% |
CAGR 5y | 8.83% |
CAGR/Max DD 5y | 0.17 |
Sharpe Ratio 12m | 0.99 |
Alpha | -18.34 |
Beta | 1.518 |
Volatility | 29.86% |
Current Volume | 646.9k |
Average Volume 20d | 1196.4k |
As of April 30, 2025, the stock is trading at USD 5.60 with a total of 646,867 shares traded.
Over the past week, the price has changed by +2.20%, over one month by -12.83%, over three months by -12.56% and over the past year by -5.75%.
Yes, based on ValueRay Fundamental Analyses, Nomura Holdings (NYSE:NMR) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.08 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NMR as of April 2025 is 4.86. This means that NMR is currently overvalued and has a potential downside of -13.21%.
Nomura Holdings has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold NMR.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, NMR Nomura Holdings will be worth about 5.3 in April 2026. The stock is currently trading at 5.60. This means that the stock has a potential downside of -5.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.2 | 27.9% |
Analysts Target Price | 7.2 | 27.9% |
ValueRay Target Price | 5.3 | -5.7% |